Noninvasive identification of significant liver fibrosis in chronic hepatitis B patients is of great value because it can be an important indication for anti-viral therapy according to EASL guideline. This abstract was to evaluate the diagnostic capability of variable flip angle native T1 mapping combined with liver stiffness measurement (LT1 model) in identifying significant liver fibrosis in chronic hepatitis B patients. The LT1 score had good sensitivity and specificity for identifying significant liver fibrosis in chronic hepatitis B patients, and could provide a reliable basis for clinical diagnosis and treatment.
This abstract and the presentation materials are available to members only; a login is required.